Merck, Moderna begin late-stage study of mRNA cancer vaccine

(Reuters) – Merck, along with its partner Moderna, began a late-stage study to evaluate their experimental mRNA-based cancer vaccine in combination with cancer therapy Keytruda, the companies said on Wednesday. Read full story

Source : https://www.thestar.com.my/news/world/2023/07/26/merck-moderna-begin-late-stage-study-of-mrna-cancer-vaccine